Endogenous cystinyl aminopeptidase in Chinese hamster ovary cells: characterization by [125I]Ang IV binding and catalytic activity.

The angiotensin II C-terminal hexapeptide fragment angiotensin IV (Ang IV) exerts central and cardiovascular effects. Cystinyl aminopeptidase (EC 3.4.11.3), a membrane-associated zinc-dependent metallopeptidase of the M1 family, has recently been found to display high affinity for Ang IV and it was proposed to represent the AT4 receptor. We present evidence for the presence of endogenous cystinyl aminopeptidase in membranes from Chinese hamster ovary (CHO-K1) cells by binding studies with [125I]Ang IV and by measuring the cleavage of L-leucine-p-nitroanilide. The equilibrium dissociation constant of [125I]Ang IV in saturation binding studies (KD= 0.90 nM) was similar to the value (KD= 0.70 nM) calculated from the association and dissociation rates. Binding was displaced with high potency by the "AT4 receptor" ligands (Ang IV > divalinal1-Ang IV approximately LVV-hemorphin-7 approximately LVV-hemorphin-6 > Ang (3-7) > Ang III > Ang (4-8)) but not by AT1/AT2 receptor antagonists. Enzymatic activity in CHO-K1 cell membranes was competitively inhibited upto 94% by Ang IV and other "AT4 receptor" ligands (Ang IV > Ang III approximately divalinal1-Ang IV approximately Ang (3-7) approximately LVV-hemorphin-7 > Ang (4-8) approximately LVV-hemorphin-6). High affinity binding of [125I]Ang IV required the presence of metal chelators and the ligands such as Ang IV and LVV-hemorphin-7 displayed higher potency in the binding studies as in the enzyme assay. This difference in potency varied from one peptide to another. These pharmacological properties match those previously reported for the recombinantly-expressed human cystinyl aminopeptidase in embryonal kidney cells.

[1]  J. Slot,et al.  The glucose transporter GLUT4 and the aminopeptidase vp165 colocalise in tubulo-vesicular elements in adipocytes and cardiomyocytes. , 1997, Journal of cell science.

[2]  J. Harding,et al.  AT4 receptor binding characteristics: d-Amino acid- and glycine-substituted peptides , 1993, Peptides.

[3]  T. Mustafa,et al.  Journal of Renin-angiotensin-aldosterone System Journal of Renin-angiotensin-aldosterone System Bioactive Angiotensin Peptides: Focus on Angiotensin Iv Journal of Renin-angiotensin-aldosterone System Additional Services and Information for Journal of the Renin- Angiotensin- Aldosterone System Bioact , 2022 .

[4]  G. Lienhard,et al.  Trafficking kinetics of the insulin-regulated membrane aminopeptidase in 3T3-L1 adipocytes. , 1997, Biochemical and biophysical research communications.

[5]  Jesper Z. Haeggström,et al.  Crystal structure of human leukotriene A4 hydrolase, a bifunctional enzyme in inflammation , 2001, Nature Structural Biology.

[6]  A. Subtil,et al.  Identification of an Insulin-responsive, Slow Endocytic Recycling Mechanism in Chinese Hamster Ovary Cells* , 1998, The Journal of Biological Chemistry.

[7]  S Mizutani,et al.  Characterization of a recombinant soluble form of human placental leucine aminopeptidase/oxytocinase expressed in Chinese hamster ovary cells. , 2000, European journal of biochemistry.

[8]  G. Guillemette,et al.  Angiotensin IV interacts with a juxtamembrane site on AT4/IRAP suggesting an allosteric mechanism of enzyme modulation , 2003, Regulatory Peptides.

[9]  K. Kandror,et al.  The major protein of GLUT4-containing vesicles, gp160, has aminopeptidase activity. , 1994, The Journal of biological chemistry.

[10]  Adipocytes exhibit abnormal subcellular distribution and translocation of vesicles containing glucose transporter 4 and insulin-regulated aminopeptidase in type 2 diabetes mellitus: implications regarding defects in vesicle trafficking. , 2001, The Journal of clinical endocrinology and metabolism.

[11]  R. K. Handa Characterization and signaling of the AT(4) receptor in human proximal tubule epithelial (HK-2) cells. , 2001, Journal of the American Society of Nephrology : JASN.

[12]  G. Servant,et al.  Characterization of a binding site for angiotensin IV on bovine aortic endothelial cells. , 1995, European journal of pharmacology.

[13]  S. Mizutani,et al.  Expression of placental leucine aminopeptidase/oxytocinase in neuronal cells and its action on neuronal peptides. , 2001, European journal of biochemistry.

[14]  G. Paxinos,et al.  Distribution of AT4 receptors in the Macaca fascicularis brain , 1996, Brain Research.

[15]  S. Mizutani Physiological roles of placental proteases in feto-placental homeostasis. , 1998, Nagoya journal of medical science.

[16]  M. Tsujimoto,et al.  Structural organization of the 5'-end and chromosomal assignment of human placental leucine aminopeptidase/insulin-regulated membrane aminopeptidase gene. , 1999, Biochemical and biophysical research communications.

[17]  S. Mizutani,et al.  Human Placental Leucine Aminopeptidase/Oxytocinase , 1996, The Journal of Biological Chemistry.

[18]  E. Kramár,et al.  Role of nitric oxide in angiotensin IV-induced increases in cerebral blood flow , 1998, Regulatory Peptides.

[19]  T. Tetaz,et al.  The Globin Fragment LVV‐Hemorphin‐7 Is an Endogenous Ligand for the AT4 Receptor in the Brain , 1997, Journal of neurochemistry.

[20]  H. Hosick,et al.  Identification and characterization of a novel angiotensin binding site in cultured vascular smooth muscle cells that is specific for the hexapeptide (3–8) fragment of angiotensin II, angiotensin IV , 1993, Regulatory Peptides.

[21]  John W. Wright,et al.  Structure-binding studies of the adrenal AT4 receptor: analysis of position two- and three-modified angiotensin IV analogs , 1999, Peptides.

[22]  R. Simpson,et al.  Evidence That the Angiotensin IV (AT4) Receptor Is the Enzyme Insulin-regulated Aminopeptidase* , 2001, The Journal of Biological Chemistry.

[23]  R. Ardaillou,et al.  Active fragments of angiotensin II: enzymatic pathways of synthesis and biological effects. , 1997, Current opinion in nephrology and hypertension.

[24]  J. Zhuo,et al.  Localization and function of angiotensin AT1 receptors. , 2000, American journal of hypertension.

[25]  G. Kovacs,et al.  Peptidergic modulation of learning and memory processes. , 1994, Pharmacological reviews.

[26]  A. Baron,et al.  Evidence for defects in the trafficking and translocation of GLUT4 glucose transporters in skeletal muscle as a cause of human insulin resistance. , 1998, The Journal of clinical investigation.

[27]  J. Wright,et al.  Structural analysis of angiotensin IV receptor (AT4) from selected bovine tissues. , 1999, The Journal of pharmacology and experimental therapeutics.

[28]  R. Lew,et al.  A Globin Fragment, LVV‐Hemorphin‐7, Induces [3H]Thymidine Incorporation in a Neuronal Cell Line via the AT4 Receptor , 1999, Journal of neurochemistry.

[29]  T. Weimbs,et al.  Identification of discrete classes of endosome-derived small vesicles as a major cellular pool for recycling membrane proteins. , 2001, Molecular biology of the cell.

[30]  S. Mizutani,et al.  Identification of human placental leucine aminopeptidase as oxytocinase. , 1992, Archives of biochemistry and biophysics.

[31]  K. Catt,et al.  International union of pharmacology. XXIII. The angiotensin II receptors. , 2000, Pharmacological reviews.

[32]  R. Somwar,et al.  Insulin regulation and selective segregation with glucose transporter-4 of the membrane aminopeptidase vp165 in rat skeletal muscle cells. , 1997, Endocrinology.

[33]  Y. Cheng,et al.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. , 1973, Biochemical pharmacology.

[34]  K. Grove,et al.  Central angiotensin IV binding sites: distribution and specificity in guinea pig brain. , 1993, The Journal of pharmacology and experimental therapeutics.

[35]  T. Mustafa,et al.  Characterization of the AT4 receptor in a human neuroblastoma cell line (SK‐N‐MC) , 2001, Journal of neurochemistry.

[36]  R. Santos,et al.  Angiotensin-(1–7): an update , 2000, Regulatory Peptides.

[37]  J. Harding,et al.  Discovery of a distinct binding site for angiotensin II (3–8), a putative angiotensin IV receptor , 1992, Regulatory Peptides.

[38]  A. Iwase,et al.  ADAMs, a disintegrin and metalloproteinases, mediate shedding of oxytocinase. , 2004, Biochemical and biophysical research communications.

[39]  S. Ye,et al.  Angiotensin AT4 ligands are potent, competitive inhibitors of insulin regulated aminopeptidase (IRAP) , 2003, Journal of neurochemistry.

[40]  R. K. Handa J Am Soc Nephrol 11: 1377–1386, 2000 Metabolism Alters the Selectivity of Angiotensin-(1-7) Receptor Ligands for Angiotensin Receptors , 2022 .

[41]  R. Ardaillou,et al.  [Active metabolites derived from angiotensin II]. , 1998, Nephrologie.

[42]  G. Lienhard,et al.  Characterization of the Insulin-regulated Membrane Aminopeptidase in 3T3-L1 Adipocytes (*) , 1996, The Journal of Biological Chemistry.

[43]  P. Timmermans,et al.  Proposed update of angiotensin receptor nomenclature. , 1995, Hypertension.

[44]  R. Aebersold,et al.  Cloning and Characterization of a Novel Insulin-regulated Membrane Aminopeptidase from Glut4 Vesicles (*) , 1995, The Journal of Biological Chemistry.

[45]  Michelle L Brennan,et al.  Structure-Activity Study of LVV-Hemorphin-7: Angiotensin AT4 Receptor Ligand and Inhibitor of Insulin-Regulated Aminopeptidase , 2003, Journal of Pharmacology and Experimental Therapeutics.

[46]  M. Birnbaum,et al.  Insulin-responsive Aminopeptidase Trafficking in 3T3-L1 Adipocytes* , 2000, The Journal of Biological Chemistry.

[47]  R. Handa,et al.  Characterization and function of the bovine kidney epithelial angiotensin receptor subtype 4 using angiotensin IV and divalinal angiotensin IV as receptor ligands. , 1999, The Journal of pharmacology and experimental therapeutics.

[48]  J. Harding,et al.  Elucidation of a specific binding site for angiotensin II(3-8), angiotensin IV, in mammalian heart membranes. , 1993, The Journal of pharmacology and experimental therapeutics.

[49]  J. Saavedra Emerging features of brain angiotensin receptors , 1999, Regulatory Peptides.

[50]  J. Harding,et al.  Characterization of a functional angiotensin IV receptor on coronary microvascular endothelial cells , 1995, Regulatory Peptides.

[51]  D. Malide,et al.  Immunocytochemical Evidence that GLUT4 Resides in a Specialized Translocation Post-endosomal VAMP2-positive Compartment in Rat Adipose Cells in the Absence of Insulin , 1997, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[52]  G. Lienhard,et al.  Insulin stimulates cell surface aminopeptidase activity toward vasopressin in adipocytes. , 1997, The American journal of physiology.

[53]  M. Czech,et al.  Signaling Mechanisms That Regulate Glucose Transport* , 1999, The Journal of Biological Chemistry.

[54]  J. Wright,et al.  AT4 receptors: specificity and distribution. , 1994, Kidney international.

[55]  Nigel M. Hooper,et al.  A Human Homolog of Angiotensin-converting Enzyme , 2000, The Journal of Biological Chemistry.